Strong nuclear TFE3 immunoreactivity, resulting from the ASPSCR1-TFE3 gene fusion, serves as a diagnostic hallmark and represents a critical molecular feature distinguishing ASPS from histologic mimics (2). The gene discussed is TFE3; the disease is alveolar soft part sarcoma.